The effect of prostacyclin (Iloprost) infusion at a dose of 1 ng/kg/min for 72 hours compared to placebo in mechanically ventilated patients with COVID-19: A structured summary of a study protocol for a randomized controlled trial

OBJECTIVES: To investigate the effect of continuous infusion of the potential endothelial cytoprotective agent prostacyclin (Iloprost) 1 ng/kg/min vs. placebo for 72 hours on pulmonary endotheliopathy in mechanically ventilated COVID-19 patients. TRIAL DESIGN: A multicenter, randomized (1:1, active:...

Descripción completa

Detalles Bibliográficos
Autores principales: Johansson, Pär Ingemar, Bestle, Morten, Søe-Jensen, Peter, Kristiansen, Klaus Tjelle, Stensballe, Jakob, Clausen, Niels Erikstrup, Perner, Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447606/
https://www.ncbi.nlm.nih.gov/pubmed/32847626
http://dx.doi.org/10.1186/s13063-020-04696-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447606/
https://www.ncbi.nlm.nih.gov/pubmed/32847626
http://dx.doi.org/10.1186/s13063-020-04696-2

Ejemplares similares